We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Oncolytics Biotech Completes Initial Scale up of Manufacturing Process for REOLYSIN®

News   May 01, 2007

 
Oncolytics Biotech Completes Initial Scale up of Manufacturing Process for REOLYSIN®
 
 
 

RELATED ARTICLES

A Nice Reactive Ring to It

News

Researchers have introduced a new synthetic process for producing an important family of carbon-based molecules known as γ-aryl-β-ketoesters. These molecules are used in the production of many vital pharmaceuticals.

READ MORE

Screening System Designed To Detect Drugs That Block Drivers of Cancer Cell Growth

News

A new screening system leverages redundancy in an important component of a cell – nucleotide metabolism – to help detect new drugs that specifically and potently block processes that are essential for cancer cell growth.

READ MORE

Scientists Produce a Potential Vitamin and Alzheimer’s Drug in Yeast

News

By engineering and optimizing baker's yeast, scientists from The Novo Nordisk Foundation Center for Biosustainability (DTU Biosustain) has for the first time exploited the potential of making ergothioneine in yeast in a bio-based fashion.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE